Taysha Gene Therapies nabs $95m Series B
Dallas-based Taysha Gene Therapies, a gene therapy company, has raised $95 million in Series B financing.
Dallas-based Taysha Gene Therapies, a gene therapy company, has raised $95 million in Series B financing.
Copyright PEI Media
Not for publication, email or dissemination